NEW YORK (TheStreet) -- Nu Skin Enterprises (NUS) - Get Report stock is slipping by 23.69% to $24.13 in early-morning trading on Friday, after the company reported lower-than-expected 2015 fourth quarter results.

After the market close on Thursday, the personal care and nutritional products posted earnings of 62 cents per share, while analysts were expecting earnings of 73 cents per share.

Revenue of $572.2 million missed analysts' forecasts for revenue of $585.92 million. Revenue fell by about 14% in South Asia/Pacific and dropped by 7% in North Asia. 

Additionally, Nu Skin projected 2016 earnings in the range of $2.40 per share to $2.60 per share, well under analysts' forecasts for full-year earnings of $3.09 per share.

Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

TheStreet Ratings rates this stock as a "hold" with a ratings score of C. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and a generally disappointing performance in the stock itself.

You can view the full analysis from the report here: NUS

Image placeholder title

NUS

data by

YCharts